RIPK3 promotes islet amyloid-induced β-cell loss and glucose intolerance in a humanized mouse model of type 2 diabetes.
Journal Information
Full Title: Mol Metab
Abbreviation: Mol Metab
Country: Unknown
Publisher: Unknown
Language: N/A
Publication Details
Related Papers from Same Journal
Transparency Score
Transparency Indicators
Click on green indicators to view evidence textCore Indicators
"Declaration of competing interest All authors declare that no competing interests exist."
"Funding This work was supported in part by funding from the U.S. Department of Veterans Affairs (IK2 BX004659 to ATT, I01 BX001060 to SEK), the 10.13039/100000002National Institutes of Health (P30 DK097512 to Indiana University Center for Diabetes and Metabolic Diseases, P30 DK017047 to University of Washington Diabetes Research Center, T32 DK064466 to Indiana University Diabetes and Obesity Research Training Program), the 10.13039/100007114Ralph W. and Grace M. Showalter Research Trust (080657-00002B to ATT), the VA Puget Sound Health Care System and the Richard L. Roudebush VA Medical Center."
Additional Indicators
Assessment Info
Tool: rtransparent
OST Version: N/A
Last Updated: Aug 05, 2025